ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
63,862.16
-0.05%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Dyadic International Inc (DYAI)

  7. Dyadic International Inc (DYAI) 뉴스

DYAI Dyadic International Inc

1.43
-0.07 (-4.67%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Dyadic International Inc DYAI 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.07 -4.67% 1.43 13:00:08
개장가 저가 고가 종가 전일 종가
1.48 1.40 1.4999 1.43 1.50
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202405:30GLOBEDyadic to Report First Quarter 2024 Financial Results on..
29/03/202405:00GLOBEDyadic Reports 2023 Full Year Results and Recent Company..
28/03/202421:30GLOBEDyadic Announces Change in Board and Management Leadership..
27/03/202421:30GLOBEDyadic to Attend Industry Events in April
26/03/202421:30GLOBEDyadic Announces Publication of C1 Monoclonal Antibody in..
21/03/202421:30GLOBEDyadic to Attend Future Food Tech Event March 21 – 22, 2024..
15/03/202405:30GLOBEDyadic to Report Full Year 2023 Financial Results and Host..
11/03/202422:57GLOBECORRECTION – Dyadic Announces Closing of Private Placement..
11/03/202421:45EDGAR2Form 8-K - Current report
11/03/202421:30GLOBEDyadic Announces Closing of Private Placement of $6.0..
01/03/202422:30GLOBEDyadic to Attend Industry Events in March
28/02/202422:30GLOBEDyadic Announces Strategic Partnership Agreement to..
21/02/202422:30GLOBEDyadic Advances Collaboration with Israel Institute for..
14/02/202406:41EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202422:30GLOBEDyadic and Cygnus Technologies Announce Partnership To..
06/02/202422:30GLOBEDyadic Announces Research and Development Collaboration..
02/02/202406:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/02/202422:30GLOBEDyadic to Attend BIO CEO & Investor Conference and European..
05/01/202410:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202410:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202410:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202410:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202410:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202410:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202410:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202410:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202410:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/01/202422:30GLOBEDyadic to Attend J.P. Morgan 42nd Annual Healthcare..
30/11/202322:30GLOBEDyadic Attends Investor Events in December
29/11/202322:30GLOBEDyadic Announces Top-Line Results from its Successful Phase..
20/11/202322:30GLOBEDyadic’s C1 Platform to be Used to Produce Vaccines..
09/11/202306:09EDGAR2Form 8-K - Current report
09/11/202306:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:00GLOBEDyadic Announces Third Quarter 2023 Financial Results and..
30/10/202321:30GLOBEDyadic to Present at Industry Events in November
26/10/202305:30GLOBEDyadic to Report Third Quarter 2023 Financial Results on..
09/10/202321:30GLOBEDyadic Appoints Doug Pace to Its Executive Leadership Team
07/10/202305:20EDGAR2Form 8-K - Current report
07/10/202305:10EDGAR2Form 8-K - Current report
05/10/202321:30GLOBEDyadic’s C1 Platform Selected by the Vaccine and..
29/09/202321:30GLOBEDyadic to Present at Industry and Investor Events in October
26/09/202321:30GLOBEDyadic and bYoRNA Announce a Collaboration Targeting the..
19/09/202321:30EDGAR2Form 8-K - Current report
19/09/202321:00GLOBEDyadic Announces Development and License Agreement to..
13/09/202305:30GLOBEDyadic to Present at BioProcess International
28/08/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
10/08/202305:10EDGAR2Form S-3 - Registration statement under Securities Act of..
10/08/202305:08EDGAR2Form 8-K - Current report
10/08/202305:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

최근 히스토리

NASDAQ
DYAI
Dyadic
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유